Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration. 1998

W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
Department of Anesthesiology, Tübingen University Hospital, Tübingen, Germany. wkrueger@rics.bwh.harvard.edu

The pharmacokinetics of meropenem were studied in nine anuric critically ill patients treated by continuous venovenous hemodiafiltration. Peak levels after infusion of 1,000 mg over 30 min amounted to 103.2 +/- 45.9 microgram/ml, and trough levels at 12 h were 9.6 +/- 3.8 microgram/ml. A dosage of 1,000 mg of meropenem twice a day provides plasma drug levels covering intermediately susceptible microorganisms. Further reductions of the dosage might be appropriate for highly susceptible bacteria or when renal replacement therapies with lower clearances are applied.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077731 Meropenem A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid,Merrem,Penem,Ronem,SM 7338,SM-7338,SM7338
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013845 Thienamycins Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors. Antibiotics, Thienamycin,Thienamycin Antibiotics
D016638 Critical Illness A disease or state in which death is possible or imminent. Critically Ill,Critical Illnesses,Illness, Critical,Illnesses, Critical
D017583 Hemodiafiltration The combination of hemodialysis and hemofiltration either simultaneously or sequentially. Convective transport (hemofiltration) may be better for removal of larger molecular weight substances and diffusive transport (hemodialysis) for smaller molecular weight solutes. Acetate-Free Biofiltration,Biofiltration, Acetate-Free,Acetate Free Biofiltration,Acetate-Free Biofiltrations,Biofiltration, Acetate Free,Biofiltrations, Acetate-Free

Related Publications

W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
May 2000, Ugeskrift for laeger,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
January 1999, Clinical pharmacology and therapeutics,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
September 1994, The International journal of artificial organs,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
August 2020, Therapeutic drug monitoring,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
December 2003, Journal of clinical pharmacology,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
January 1993, ASAIO journal (American Society for Artificial Internal Organs : 1992),
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
September 1993, Journal of critical care,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
January 1991, Contributions to nephrology,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
January 1992, Renal failure,
W A Krueger, and T H Schroeder, and M Hutchison, and E Hoffmann, and H J Dieterich, and A Heininger, and C Erley, and A Wehrle, and K Unertl
January 1995, Journal of intensive care medicine,
Copied contents to your clipboard!